Zymeworks Inc. Common Shares (ZYME) Social Stream
ZYMEWORKS INC (ZYME) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ZYME.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 8 | $74 | $28 | $48.875 | $10.56 | 362.83% |
| 2021-11-10 | 8 | $74 | $27 | $48.75 | $10.56 | 361.65% |
| 2021-11-17 | 9 | $74 | $27 | $47.875 | $10.56 | 353.36% |
| 2021-12-10 | 9 | $74 | $27 | $47.875 | $10.56 | 353.36% |
| 2021-12-14 | 9 | $74 | $27 | $45.375 | $10.56 | 329.69% |
| 2022-01-24 | 8 | $51 | $27 | $40.857 | $10.56 | 286.9% |
| 2022-02-01 | 8 | $51 | $27 | $37.571 | $10.56 | 255.79% |
| 2022-02-24 | 8 | $51 | $18 | $34.714 | $10.56 | 228.73% |
| 2022-03-15 | 9 | $44 | $15 | $28.875 | $10.56 | 173.44% |
| 2022-04-13 | 9 | $44 | $15 | $27.125 | $10.56 | 156.87% |
| 2022-05-02 | 8 | $44 | $15 | $27.142 | $10.56 | 157.03% |
| 2022-05-05 | 8 | $44 | $14 | $25.5 | $10.56 | 141.48% |
| 2022-05-23 | 8 | $40 | $14 | $24.625 | $10.56 | 133.19% |
| 2022-05-27 | 8 | $40 | $14 | $22.875 | $10.56 | 116.62% |
| 2022-08-04 | 8 | $40 | $14 | $22.375 | $10.56 | 111.88% |
| 2022-08-09 | 8 | $40 | $7.7 | $20.1 | $10.56 | 90.34% |
| 2022-08-10 | 8 | $40 | $7.7 | $19.337 | $10.56 | 83.12% |
| 2022-09-05 | 9 | $40 | $7.7 | $20.189 | $10.56 | 91.18% |
| 2022-09-14 | 9 | $40 | $7.7 | $19.522 | $10.56 | 84.87% |
| 2022-10-04 | 9 | $40 | $7.7 | $18.47 | $10.56 | 74.91% |
| 2022-10-24 | 10 | $40 | $7.7 | $17.62 | $10.56 | 66.86% |
| 2022-10-26 | 10 | $40 | $7.7 | $16.52 | $10.56 | 56.44% |
| 2022-10-28 | 10 | $40 | $7 | $15.82 | $10.56 | 49.81% |
| 2022-11-09 | 10 | $21 | $7 | $12.62 | $10.56 | 19.51% |
| 2022-11-21 | 10 | $21 | $7 | $12.82 | $10.56 | 21.4% |
| 2022-12-20 | 10 | $21 | $7 | $13.15 | $10.56 | 24.53% |
| 2022-12-22 | 11 | $21 | $8 | $12.863 | $10.56 | 21.81% |
| 2023-01-17 | 11 | $21 | $8 | $12.681 | $10.56 | 20.09% |
| 2023-03-07 | 11 | $21 | $8 | $13.045 | $10.56 | 23.53% |
| 2023-03-08 | 11 | $21 | $8 | $13.136 | $10.56 | 24.39% |
| 2023-03-10 | 11 | $18.5 | $8 | $12.55 | $10.56 | 18.84% |
| 2023-03-21 | 10 | $18.5 | $8 | $12.85 | $10.56 | 21.69% |
| 2023-04-25 | 10 | $18.5 | $8 | $12.95 | $10.56 | 22.63% |
| 2023-05-08 | 9 | $18.5 | $8 | $12.95 | $10.56 | 22.63% |
| 2023-05-09 | 9 | $19 | $8 | $13.05 | $10.56 | 23.58% |
| 2023-08-15 | 9 | $19 | $8 | $13.15 | $10.56 | 24.53% |
| 2023-11-13 | 8 | $19 | $8 | $12.666 | $10.56 | 19.94% |
| 2023-12-01 | 10 | $19 | $8 | $12.555 | $10.56 | 18.89% |
The Trend in the Analyst Price Target
ZYME's average price target has moved down $40.74 over the prior 43 months.
Over the past 45 weeks, ZYME's average upside potential has been 53.87%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-10 | 10 | 18.5 | 8 | 12.772 | 7.93 | 61.06% |
| 2023-03-10 | 11 | 18.5 | 8 | 12.772 | 7.93 | 61.06% |
| 2023-08-15 | 9 | 19.0 | 8 | 12.555 | 7.42 | 69.2% |
| 2023-12-01 | 10 | 19.0 | 8 | 13.000 | 9.15 | 42.08% |
| 2023-12-01 | 9 | 19.0 | 8 | 13.000 | 9.15 | 42.08% |
ZYME Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.89 | 5 | 0 | 4 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 17 months, ZYME's average broker recommendation rating worsened by 0.3.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how ZYMEWORKS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -4115.25% of that group.
- In terms of how ZYMEWORKS INC fares relative to all US stocks, note that its average analyst price target is greater than 1238.77% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, ZYMEWORKS INC's upside potential (average analyst target price relative to current price) is greater than 3225.94% of them.
- ZYME has a greater number of analysts covering the stock than 3045.3% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, HCM, ORGO, and BPMC are the three stocks most similar to ZYMEWORKS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for ZYME? Use POWR Ratings for clearer insight into price direction.